Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca sells Atacand rights to Cheplapharm

pharmatimesJuly 25, 2018

Tag: candesartan cilexetil , AstraZeneca , Heart failure , Cheplapharm

PharmaSources Customer Service